Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HEALTHEQUITY, INC. Director's Dealing 2017

Aug 30, 2017

30722_dirs_2017-08-30_acc23621-7515-4283-bebe-a6e1635e572f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HEALTHEQUITY INC (HQY)
CIK: 0001428336
Period of Report: 2017-08-28

Reporting Person: Soldan Jon (Exec VP, Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-08-28 Common Stock M 25000 $28.69 Acquired 30652 Direct
2017-08-28 Common Stock S 25000 $40.6829 Disposed 5652 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-08-28 Stock Option (right to buy) $28.69 M 25000 Disposed 2025-08-26 Common Stock (25000) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy) $24.36 2026-03-23 Common Stock (18750) 18750 Direct

Footnotes

F1: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.39 to $41.11, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

F3: The option became exercisable as to 25,000 shares on August 26, 2017. The option becomes exercisable as to the remaining 50,000 shares in two equal installments of 25,000 on August 26, 2018 and 2019.

F4: The option became exercisable as to 6,250 shares on March 23, 2017. The option becomes exercisable as to the remaining 18,750 shares in thee equal annual installments of 6,250 on March 23, 2018, 2019 and 2020.